… coronavirus-2 (SARS-CoV-2) plays an essential role in infection and is an important target for
neutralizing antibody recognition… , resistance to neutralizing antibodies and immune escape…

… In this study, we determined antibody responses to SARS-CoV-2 … no prior exposure to
SARS-CoV-2. Moreover, we mapped … commonly recognized by antibodies from many SARS-CoV-2…

… We correlated positively reacting peptides with the in vitro SARS-CoV … activity recognized
exclusively only a limited number of peptides on the membranes. This suggests that antibodies …

… creates a shield that blocks antibody recognition, but some of the … antibody S309 neutralizes
both SARS-CoV and SARS-CoV-2, glycan-based vaccine or broad neutralizing antibody …

… individuals generate neutralizing antibodies recognizing a focused target on the RBD.
Resistance to inhibition by soluble recombinant human ACE2, a candidate decoy molecule drug ( …

… level of reactivity to SARS-CoV-2, we find only partial cross-neutralization for the spike antibodies.
The … First, we establish a set of antibodies with known reactivity to both SARS-CoV and …

… Potent neutralising antibodies to the RBD of SARS-CoV-2 spike glycoprotein were identified
and we then analysed the blockade of the ACE2-RBD interaction by anti-RBD antibodies in …

… detectable SARS-CoV-2-specific antibodies recognizing the … sustainability of SARS-CoV-2-specific
antibodies is associated … a more rapid decay of antibody levels during the first months …

… survivor obtained 10 years after recovery, that neutralizes SARS-CoV-2 and SARS-CoV
through recognition of the S receptor–binding domain (RBD) but without blocking ACE2 …

… ACE2 expression) stably transduced with full-length SARS-CoV-2 S. Syncytia formation was
triggered by all monoclonal antibodies recognizing antigenic sites Ia and IIa (Extended Data …